In 2025, Airbus Defence and Space reported revenues of 13.4 billion euros ($14.5 billion), an 11% increase from 12.1 billion ...

CAMP4 Therapeutics Corporation (“CAMP4”) (Nasdaq: CAMP), a clinical-stage biopharmaceutical company developing a pipeline of regulatory RNA-targeting therapeutics designed to upregulate gene ...

An ASU research team is using innovative practices to attempt to decrease or even reverse the impacts of aging.

Wyden said Lt. Gen. Joshua Rudd, who currently serves as the deputy commander of U.S. Indo-Pacific Command, lacks the ...

Total proposed revenue for the district is expected to reach $71,344,862, with 36 per cent coming from tax requisitions, 19 ...

Wave Quantum Inc. (NYSE: QBTS) ("D-Wave" or the "Company"), the only dual-platform quantum computing company, providing both ...

Delivered strong full year 2025 results Completed Initial Public Offering Introduced full year 2026 guidance Fourth quarter net sales of $7.8 ...

As with so many core functions of public health, the future success of vaccine promotion research depends on the support of every institution: government, universities, and industry alike.

Net sales in the fourth quarter of 2025 increased 9% versus the fourth quarter of 2024.Gross profit in the fourth quarter of ...

This story was originally published by Capital & Main. A unique aerial measurement campaign found that emission inventories ...

Two new drug applications (NDA) for ulixacaltamide in essential tremor (ET) and for relutrigine in SCN2A and SCN8A developmental and epileptic ...

Energy Transfer LP Common Units delivered solid Q4 2025 results, with strong revenue and cash flow growth. Learn more about ET stock here.